Armata Pharmaceuticals Inc (ARMP)
2.76
+0.23
(+9.06%)
USD |
NYAM |
Apr 26, 16:00
2.76
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Enterprise Value: 168.55M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 168.55M |
| April 25, 2024 | 160.26M |
| April 24, 2024 | 159.15M |
| April 23, 2024 | 160.23M |
| April 22, 2024 | 159.51M |
| April 19, 2024 | 165.11M |
| April 18, 2024 | 160.96M |
| April 17, 2024 | 159.15M |
| April 16, 2024 | 184.45M |
| April 15, 2024 | 185.54M |
| April 12, 2024 | 186.26M |
| April 11, 2024 | 188.43M |
| April 10, 2024 | 191.68M |
| April 09, 2024 | 199.27M |
| April 08, 2024 | 199.27M |
| April 05, 2024 | 205.42M |
| April 04, 2024 | 203.25M |
| April 03, 2024 | 200.72M |
| April 02, 2024 | 201.08M |
| April 01, 2024 | 209.76M |
| March 28, 2024 | 219.88M |
| March 27, 2024 | 216.99M |
| March 26, 2024 | 214.82M |
| March 25, 2024 | 210.12M |
| March 22, 2024 | 203.97M |
| Date | Value |
|---|---|
| March 21, 2024 | 202.16M |
| March 20, 2024 | 196.75M |
| March 19, 2024 | 205.43M |
| March 18, 2024 | 193.13M |
| March 15, 2024 | 198.92M |
| March 14, 2024 | 190.88M |
| March 13, 2024 | 193.41M |
| March 12, 2024 | 200.63M |
| March 11, 2024 | 190.88M |
| March 08, 2024 | 197.02M |
| March 07, 2024 | 197.02M |
| March 06, 2024 | 202.80M |
| March 05, 2024 | 204.97M |
| March 04, 2024 | 217.61M |
| March 01, 2024 | 215.80M |
| February 29, 2024 | 211.11M |
| February 28, 2024 | 208.94M |
| February 27, 2024 | 196.30M |
| February 26, 2024 | 176.79M |
| February 23, 2024 | 177.15M |
| February 22, 2024 | 173.54M |
| February 21, 2024 | 174.26M |
| February 20, 2024 | 171.37M |
| February 16, 2024 | 174.99M |
| February 15, 2024 | 185.10M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.970M
Minimum
Apr 29 2019
219.88M
Maximum
Mar 28 2024
82.15M
Average
77.45M
Median
Aug 16 2021
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 8.987M |
| Perspective Therapeutics Inc | 919.81M |
| Protalix BioTherapeutics Inc | 59.70M |
| Electromed Inc | 125.27M |
| Xtant Medical Holdings Inc | 139.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.85M |
| Total Expenses (Quarterly) | 9.579M |
| EPS Diluted (Quarterly) | -0.55 |
| Earnings Yield | -71.74% |
| Normalized Earnings Yield | -1526.85 |